Aging-US - Peeref

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

Aging-US

AGING-US

ISSN / eISSN

1945-4589 / 1945-4589

Aims and Scope

Information not localized

Subject Area

CELL BIOLOGY

GERIATRICS & GERONTOLOGY

CiteScore

9.30

View Trend

CiteScore Ranking

Category	Quartile	Rank
Biochemistry, Genetics and Molecular Biology - Aging	Q1	#8/35
Biochemistry, Genetics and Molecular Biology - Cell Biology	Q2	#70/274

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
CELL BIOLOGY - SCIE	Q2
GERIATRICS & GERONTOLOGY - SCIE	Q2

H-index

Country/Area of Publication

UNITED STATES

Publisher

Impact Journals LLC

Publication Frequency

Monthly

Year Publication Started

2008

Annual Article Volume

585

Open Access

Contact

IMPACT JOURNALS LLC, 6211 TIPTON HOUSE, STE 6, ALBANY, USA, NY, 12203

Popular journals in the same field
Recent articles

Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma: (2023) Zhenyong Xiao, Jinwei Li, Cong Liang, Yamei Liu, Yuxiu Zhang, Yuxia Zhang, Quan Liu, Xianlei Yan

Polyphyllin I attenuates the invasion and metastasis via downregulating GRP78 in drug-resistant hepatocellular carcinoma cells: (2023) Haiyan Du, Haochen Wu, Qinyang Kang, Mianmian Liao, Meirong Qin, Ning Chen, Houshuang Huang, Danping Huang, Ping Wang, Guangdong Tong

A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma: (2023) Yangxia Chen, Di Hu, Fang Wang, Cheng Huang, Hesong Xie, Ling Jin

Collaborating single-cell and bulk RNA sequencing for comprehensive characterization of the bladder cancer intratumor heterogeneity and prognostic model development for bladder cancer: (2023) Jie Wang, Zili Zuo, Zongze Yu, Zhigui Chen, Lisa Jia Tran, Jing Zhang, Jinsong Ao, Fangdie Ye, Zhou Sun

Influences and mechanism of erythropoietin on the cognitive function of vascular dementia rats: (2023) Zhipeng Tang, Xiuqin Li, Nan Yin, Ming Zhao, Qingchuan Hu, Peiyuan Lv

N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy: (2023) Liping Ma, Qingwei Ma, Qiaomei Deng, Jilu Zhou, Yingpei Zhou, Qianqian Wei, Zhihu Huang, Xiaoxia Lao, Ping Du

Longitudinal characterization of behavioral, morphological and transcriptomic changes in a tauopathy mouse model: (2023) Qing Cao, Manasa Kumar, Allea Frazier, Jamal B. Williams, Shengkai Zhao, Zhen Yan

Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin: (2023) Yuqi Xin, Qingkun Jiang, Chenshu Liu, Jiaxuan Qiu

Multi-omics analysis reveals PUS1 triggered malignancy and correlated with immune infiltrates in NSCLC: (2023) Yonghuang Tan, Zhaotong Wang, Yingzhao Wang, Xiaolu Tian, Yunru Huang, Guoyong Wu, Jianjun Lu

Identification of circRNA-miRNA-mRNA network as biomarkers for interstitial cystitis/bladder pain syndrome: (2023) Shi-Qin Yang, Liao peng, Le-De Lin, Yuan-Zhuo Chen, Meng-Zhu Liu, Chi Zhang, Jia-Wei Chen, De-yi Luo

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

This journal is still pretty good, and the editors are industry experts. However, as others have mentioned, the cost of the magazine layout is expensive. In 2019, the journal suddenly accepted more than double the number of articles, and there were too many submissions from Chinese authors. These are all warning signs for evaluation by the Chinese Academy of Sciences. If the journal does not improve its acceptance rate, it may be removed from SCI. However, objectively speaking, many articles in this journal are meaningful and not superficial, and the self-citation rate is also low. Therefore, it is reasonable to classify it as a top journal in the field of geriatric medicine. It's just that the two evaluation criteria are different.

2021-01-21

The magazine is very good, and the quality of the papers published in the same period is also very high. The reviewers are also very responsible and raised many good questions. The only problem is that the review process is too slow, taking more than three months. If it weren't for seeing the email, I would have forgotten that I had submitted an article here...

2022-09-22

View All Reviews

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started